Optimax Holdings Bhd (XKLS:0222) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKLS:0222 Optimax Holdings Bhd XKLS:0222
70 GF Score
Price RM0.53
GF Value RM0.76
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Optimax Holdings Bhd FFO per Share?

FFO per Share only applies to REITs.

XKLS:0222
70GF Score
Optimax Holdings Bhd XKLS:0222
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Optimax Holdings Bhd (XKLS:0222) Overvalued in 2026?

Based on GuruFocus' analysis, Optimax Holdings Bhd stock appears to be undervalued. The current stock price of RM0.53 is trading 30.9% below its estimated GF Value™ of RM0.76. GuruFocus considers Optimax Holdings Bhd to be Significantly Undervalued.

Key valuation signals for XKLS:0222:

  • FFO per Share:
  • GF Value™: RM0.76 vs. price of RM0.53 (30.9% below fair value)
  • GF Score™: 70/100 with 2 warning signs

No single metric tells the full story. See the XKLS:0222 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Optimax Holdings Bhd Business Description

Address No. 145, Jalan Radin Bagus, 1st and 2nd Floor, Seri Petaling, Wilayah Persekutuan, Kuala Lumpur, SGR, MYS, 57000
Optimax Holdings Bhd is a provider of eye specialist services. The company offers a range of services with in-house medical ophthalmology at specialist centres such as specialist clinics, ambulatory care centres, satellite clinics, and specialist hospitals. The company's ambulatory care centres and specialist hospital are equipped with eye operation theatres, and procedure rooms, general and day care wards, and relevant equipment for surgical procedures. It derives revenue from refractive surgery, treatment of eye diseases and disorders, consultation and dispensary services, oculoplastic surgery, plastic Surgery and aesthetic Services and related services. The company operates in geographical segments such as: North Malaysia, Central Malaysia, South Malaysia, East Malaysia and Cambodia.
70GF Score

Get the complete analysis for XKLS:0222

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM0.53
Price
RM0.76
GF Value